Verrica Pharmaceuticals Inc (VRCA)
1.00
+0.01
(+1.01%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
0.00 (0.00%)
After-Hours: 17:17
Verrica Pharmaceuticals Market Cap: 45.60M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 45.14M |
| November 20, 2024 | 40.47M |
| November 19, 2024 | 40.58M |
| November 18, 2024 | 40.50M |
| November 15, 2024 | 38.01M |
| November 14, 2024 | 39.37M |
| November 13, 2024 | 38.56M |
| November 12, 2024 | 41.95M |
| November 11, 2024 | 43.86M |
| November 08, 2024 | 37.84M |
| November 07, 2024 | 32.12M |
| November 06, 2024 | 34.03M |
| November 05, 2024 | 36.37M |
| November 04, 2024 | 65.21M |
| November 01, 2024 | 69.77M |
| October 31, 2024 | 63.84M |
| October 30, 2024 | 72.96M |
| October 29, 2024 | 76.61M |
| October 28, 2024 | 71.14M |
| October 25, 2024 | 68.86M |
| October 24, 2024 | 68.40M |
| October 23, 2024 | 68.86M |
| October 22, 2024 | 72.51M |
| October 21, 2024 | 71.59M |
| October 18, 2024 | 72.96M |
| Date | Value |
|---|---|
| October 17, 2024 | 66.58M |
| October 16, 2024 | 68.86M |
| October 15, 2024 | 63.39M |
| October 14, 2024 | 64.75M |
| October 11, 2024 | 61.11M |
| October 10, 2024 | 58.82M |
| October 09, 2024 | 58.37M |
| October 08, 2024 | 58.37M |
| October 07, 2024 | 61.11M |
| October 04, 2024 | 59.74M |
| October 03, 2024 | 66.12M |
| October 02, 2024 | 50.62M |
| October 01, 2024 | 62.47M |
| September 30, 2024 | 66.12M |
| September 27, 2024 | 72.11M |
| September 26, 2024 | 71.68M |
| September 25, 2024 | 70.83M |
| September 24, 2024 | 75.10M |
| September 23, 2024 | 74.67M |
| September 20, 2024 | 77.23M |
| September 19, 2024 | 82.78M |
| September 18, 2024 | 78.94M |
| September 17, 2024 | 75.52M |
| September 16, 2024 | 80.64M |
| September 13, 2024 | 84.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
32.12M
Minimum
Nov 07 2024
449.26M
Maximum
Nov 26 2019
241.72M
Average
247.27M
Median
Jan 22 2024
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.24B |
| Elite Pharmaceuticals Inc | 658.91M |
| Eagle Pharmaceuticals Inc | 12.34M |
| TELA Bio Inc | 118.36M |
| Terns Pharmaceuticals Inc | 491.80M |
Market Cap Related Metrics
| PS Ratio | 5.052 |
| PEG Ratio | -0.0076 |
| Price | 1.00 |
| Earnings Yield | -184.0% |
| PEGY Ratio | -0.0076 |